Monson, Kathryn
Brighton and Sussex Medical School · University of Sussex
2 papers on CoChat
Most cited papers
- Verified
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L., et al. (2014) · Annals of Oncology
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 177
- Verified
Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study
Fallowfield, L., Osborne, S., Langridge, C., Monson, K., Kilkerr, J., & Jenkins, V. (2015) · The Breast
HER2/EGFR in Cancer ResearchHealth Systems, Economic Evaluations, Quality of Life
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free